位置:首页 > 蛋白库 > VPAP_HCMVA
VPAP_HCMVA
ID   VPAP_HCMVA              Reviewed;         433 AA.
AC   P16790; Q7M6P1;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   03-AUG-2022, entry version 99.
DE   RecName: Full=DNA polymerase processivity factor;
DE   AltName: Full=Polymerase accessory protein;
DE            Short=PAP;
DE   AltName: Full=Protein ICP36;
GN   Name=UL44;
OS   Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5).
OC   Viruses; Duplodnaviria; Heunggongvirae; Peploviricota; Herviviricetes;
OC   Herpesvirales; Herpesviridae; Betaherpesvirinae; Cytomegalovirus.
OX   NCBI_TaxID=10360;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-27.
RX   PubMed=2538657; DOI=10.1128/jvi.63.4.1783-1791.1989;
RA   Leach F.S., Mocarski E.S.;
RT   "Regulation of cytomegalovirus late-gene expression: differential use of
RT   three start sites in the transcriptional activation of ICP36 gene
RT   expression.";
RL   J. Virol. 63:1783-1791(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=2161319; DOI=10.1007/978-3-642-74980-3_6;
RA   Chee M.S., Bankier A.T., Beck S., Bohni R., Brown C.M., Cerny R.,
RA   Horsnell T., Hutchison C.A. III, Kouzarides T., Martignetti J.A.,
RA   Preddie E., Satchwell S.C., Tomlinson P., Weston K.M., Barrell B.G.;
RT   "Analysis of the protein-coding content of the sequence of human
RT   cytomegalovirus strain AD169.";
RL   Curr. Top. Microbiol. Immunol. 154:125-169(1990).
RN   [3]
RP   GENOME REANNOTATION.
RX   PubMed=12533697; DOI=10.1099/vir.0.18606-0;
RA   Davison A.J., Dolan A., Akter P., Addison C., Dargan D.J., Alcendor D.J.,
RA   McGeoch D.J., Hayward G.S.;
RT   "The human cytomegalovirus genome revisited: comparison with the chimpanzee
RT   cytomegalovirus genome.";
RL   J. Gen. Virol. 84:17-28(2003).
RN   [4]
RP   ERRATUM OF PUBMED:12533697.
RA   Davison A.J., Dolan A., Akter P., Addison C., Dargan D.J., Alcendor D.J.,
RA   McGeoch D.J., Hayward G.S.;
RL   J. Gen. Virol. 84:1053-1053(2003).
RN   [5]
RP   INTERACTION WITH UL54, AND MUTAGENESIS OF ILE-135.
RX   PubMed=14671097; DOI=10.1128/jvi.78.1.158-167.2004;
RA   Loregian A., Appleton B.A., Hogle J.M., Coen D.M.;
RT   "Residues of human cytomegalovirus DNA polymerase catalytic subunit UL54
RT   that are necessary and sufficient for interaction with the accessory
RT   protein UL44.";
RL   J. Virol. 78:158-167(2004).
RN   [6]
RP   IDENTIFICATION.
RX   PubMed=15452216; DOI=10.1128/jvi.78.20.10960-10966.2004;
RA   Varnum S.M., Streblow D.N., Monroe M.E., Smith P., Auberry K.J.,
RA   Pasa-Tolic L., Wang D., Camp D.G. II, Rodland K., Wiley S., Britt W.,
RA   Shenk T., Smith R.D., Nelson J.A.;
RT   "Identification of proteins in human cytomegalovirus (HCMV) particles: the
RT   HCMV proteome.";
RL   J. Virol. 78:10960-10966(2004).
RN   [7]
RP   ERRATUM OF PUBMED:15452216.
RA   Varnum S.M., Streblow D.N., Monroe M.E., Smith P., Auberry K.J.,
RA   Pasa-Tolic L., Wang D., Camp D.G. II, Rodland K., Wiley S., Britt W.,
RA   Shenk T., Smith R.D., Nelson J.A.;
RL   J. Virol. 78:13395-13395(2004).
RN   [8]
RP   OLIGOMERIZATION.
RX   PubMed=18842734; DOI=10.1128/jvi.01193-08;
RA   Sinigalia E., Alvisi G., Mercorelli B., Coen D.M., Pari G.S., Jans D.A.,
RA   Ripalti A., Palu G., Loregian A.;
RT   "Role of homodimerization of human cytomegalovirus DNA polymerase accessory
RT   protein UL44 in origin-dependent DNA replication in cells.";
RL   J. Virol. 82:12574-12579(2008).
RN   [9]
RP   INTERACTION WITH UL114.
RX   PubMed=18599070; DOI=10.1016/j.jmb.2008.05.028;
RA   Ranneberg-Nilsen T., Dale H.A., Luna L., Slettebakk R., Sundheim O.,
RA   Rollag H., Bjoras M.;
RT   "Characterization of human cytomegalovirus uracil DNA glycosylase (UL114)
RT   and its interaction with polymerase processivity factor (UL44).";
RL   J. Mol. Biol. 381:276-288(2008).
RN   [10]
RP   INTERACTION WITH UL84.
RX   PubMed=19457994; DOI=10.1128/jvi.00663-09;
RA   Strang B.L., Sinigalia E., Silva L.A., Coen D.M., Loregian A.;
RT   "Analysis of the association of the human cytomegalovirus DNA polymerase
RT   subunit UL44 with the viral DNA replication factor UL84.";
RL   J. Virol. 83:7581-7589(2009).
RN   [11]
RP   INTERACTION WITH UL112/113, AND FUNCTION.
RX   PubMed=20538862; DOI=10.1128/jvi.00189-10;
RA   Kim Y.E., Ahn J.H.;
RT   "Role of the specific interaction of UL112-113 p84 with UL44 DNA polymerase
RT   processivity factor in promoting DNA replication of human
RT   cytomegalovirus.";
RL   J. Virol. 84:8409-8421(2010).
RN   [12]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=20739543; DOI=10.1128/jvi.01033-10;
RA   Silva L.A., Loregian A., Pari G.S., Strang B.L., Coen D.M.;
RT   "The carboxy-terminal segment of the human cytomegalovirus DNA polymerase
RT   accessory subunit UL44 is crucial for viral replication.";
RL   J. Virol. 84:11563-11568(2010).
RN   [13]
RP   PHOSPHORYLATION AT SER-413; SER-415 AND SER-418, AND SUBCELLULAR LOCATION.
RX   PubMed=21784501; DOI=10.1016/j.virol.2011.06.008;
RA   Silva L.A., Strang B.L., Lin E.W., Kamil J.P., Coen D.M.;
RT   "Sites and roles of phosphorylation of the human cytomegalovirus DNA
RT   polymerase subunit UL44.";
RL   Virology 417:268-280(2011).
RN   [14]
RP   INTERACTION WITH HOST NCL, AND FUNCTION.
RX   PubMed=22318319; DOI=10.1128/mbio.00301-11;
RA   Strang B.L., Boulant S., Kirchhausen T., Coen D.M.;
RT   "Host cell nucleolin is required to maintain the architecture of human
RT   cytomegalovirus replication compartments.";
RL   MBio 3:255-260(2012).
RN   [15]
RP   INTERACTION WITH HOST SMARCB1.
RX   PubMed=22479537; DOI=10.1371/journal.pone.0034119;
RA   Ranneberg-Nilsen T., Rollag H., Slettebakk R., Backe P.H., Olsen O.,
RA   Luna L., Bjoras M.;
RT   "The chromatin remodeling factor SMARCB1 forms a complex with human
RT   cytomegalovirus proteins UL114 and UL44.";
RL   PLoS ONE 7:E34119-E34119(2012).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH HOST IRF3 AND HOST
RP   RELA.
RX   PubMed=30867312; DOI=10.1128/jvi.00181-19;
RA   Fu Y.Z., Su S., Zou H.M., Guo Y., Wang S.Y., Li S., Luo M.H., Wang Y.Y.;
RT   "Human Cytomegalovirus DNA Polymerase Subunit UL44 Antagonizes Antiviral
RT   Immune Responses by Suppressing IRF3- and NF-kappaB-Mediated
RT   Transcription.";
RL   J. Virol. 93:0-0(2019).
RN   [17]
RP   FUNCTION, SUMOYLATION, MUTAGENESIS OF LYS-410, AND INTERACTION WITH HOST
RP   UBC9.
RX   PubMed=33967989; DOI=10.3389/fmicb.2021.652719;
RA   Chen J., Li G., He H., Li X., Niu W., Cao D., Shen A.;
RT   "Sumoylation of the Carboxy-Terminal of Human Cytomegalovirus DNA
RT   Polymerase Processivity Factor UL44 Attenuates Viral DNA Replication.";
RL   Front. Microbiol. 12:652719-652719(2021).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1-290.
RX   PubMed=15260974; DOI=10.1016/j.molcel.2004.06.018;
RA   Appleton B.A., Loregian A., Filman D.J., Coen D.M., Hogle J.M.;
RT   "The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped
RT   dimer.";
RL   Mol. Cell 15:233-244(2004).
CC   -!- FUNCTION: Accessory subunit of the DNA polymerase that plays an
CC       essential role in viral DNA replication and acts by increasing the
CC       processivity of polymerization (PubMed:20538862, PubMed:20739543,
CC       PubMed:33967989). Forms dimers that binds to double-stranded DNA and
CC       UL54 specifically to stimulates long chain DNA synthesis efficiently.
CC       Plays an important role in maintaining the structure of viral
CC       replication compartments by interacting with host nucleolin/NUC
CC       (PubMed:22318319). In addition, suppresses innate immune responses
CC       through effects on host IRF3 and NF-kappa-B. Mechanistically, interfere
CC       with the binding of IRF3 and the p65 NF-kappa-B subunit to the
CC       promoters of antiviral genes, thereby inhibiting the expression of
CC       these genes (PubMed:30867312). {ECO:0000269|PubMed:20538862,
CC       ECO:0000269|PubMed:20739543, ECO:0000269|PubMed:22318319,
CC       ECO:0000269|PubMed:30867312, ECO:0000269|PubMed:33967989}.
CC   -!- SUBUNIT: Forms homodimers. Interacts with host SMARCB1. Interacts with
CC       host NCL/nucleolin; this interaction is important for the organization
CC       of proteins within viral replication compartments. Interacts with
CC       UL112/UL113; this interaction is necessary for efficient viral DNA
CC       replication. Interacts with UL84. Interacts with the uracil DNA
CC       glycosylase UL114. Interacts with the DNA polymerase catalytic subunit
CC       UL54. Interacts with host IRF3 (PubMed:30867312). Interacts with host
CC       RELA (PubMed:30867312). {ECO:0000269|PubMed:14671097,
CC       ECO:0000269|PubMed:18599070, ECO:0000269|PubMed:19457994,
CC       ECO:0000269|PubMed:20538862, ECO:0000269|PubMed:22318319,
CC       ECO:0000269|PubMed:22479537}.
CC   -!- SUBCELLULAR LOCATION: Virion. Host nucleus
CC       {ECO:0000269|PubMed:20739543, ECO:0000269|PubMed:21784501,
CC       ECO:0000269|PubMed:30867312}.
CC   -!- DOMAIN: The C-terminal region is required for viral DNA synthesis.
CC       {ECO:0000269|PubMed:20739543}.
CC   -!- PTM: Phosphorylated by UL97 on serine residues, phosphorylation seems
CC       important for UL44 nuclear entry but does not directly affect its role
CC       in replication. {ECO:0000269|PubMed:21784501}.
CC   -!- PTM: Sumoylated. Sumoylation on Lys-410 increases viral DNA
CC       replication. {ECO:0000269|PubMed:33967989}.
CC   -!- SIMILARITY: Belongs to the herpesviridae polymerase accessory protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X17403; CAA35403.1; -; Genomic_DNA.
DR   EMBL; BK000394; DAA00147.1; -; Genomic_DNA.
DR   PIR; S09807; QQBEV2.
DR   PDB; 1T6L; X-ray; 1.85 A; A=1-290.
DR   PDB; 1YYP; X-ray; 2.50 A; A=1-290.
DR   PDB; 5IWD; X-ray; 2.56 A; A=1-290.
DR   PDB; 5IXA; X-ray; 2.68 A; A/B=1-290.
DR   PDBsum; 1T6L; -.
DR   PDBsum; 1YYP; -.
DR   PDBsum; 5IWD; -.
DR   PDBsum; 5IXA; -.
DR   SMR; P16790; -.
DR   DIP; DIP-46029N; -.
DR   ELM; P16790; -.
DR   IntAct; P16790; 1.
DR   PRIDE; P16790; -.
DR   EvolutionaryTrace; P16790; -.
DR   Proteomes; UP000008991; Genome.
DR   Proteomes; UP000008992; Genome.
DR   GO; GO:0042025; C:host cell nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0030337; F:DNA polymerase processivity factor activity; IEA:InterPro.
DR   GO; GO:0039686; P:bidirectional double-stranded viral DNA replication; IDA:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0039644; P:suppression by virus of host NF-kappaB cascade; IEA:UniProtKB-KW.
DR   GO; GO:0039548; P:suppression by virus of host viral-induced cytoplasmic pattern recognition receptor signaling pathway via inhibition of IRF3 activity; IEA:UniProtKB-KW.
DR   InterPro; IPR004997; Herpes_PAP.
DR   Pfam; PF03325; Herpes_PAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; DNA replication; DNA-binding; Host nucleus;
KW   Host-virus interaction; Inhibition of host innate immune response by virus;
KW   Inhibition of host IRF3 by virus; Inhibition of host NF-kappa-B by virus;
KW   Inhibition of host RLR pathway by virus; Isopeptide bond; Phosphoprotein;
KW   Reference proteome; Ubl conjugation; Viral DNA replication;
KW   Viral immunoevasion; Virion.
FT   CHAIN           1..433
FT                   /note="DNA polymerase processivity factor"
FT                   /id="PRO_0000116070"
FT   REGION          274..433
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        363..377
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21784501"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21784501"
FT   MOD_RES         418
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:21784501"
FT   CROSSLNK        410
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in host SUMO1)"
FT                   /evidence="ECO:0000269|PubMed:33967989"
FT   MUTAGEN         135
FT                   /note="I->A: Complete loss of interaction with UL54."
FT                   /evidence="ECO:0000269|PubMed:14671097"
FT   MUTAGEN         410
FT                   /note="K->A: Complete loss of sumoylation and enhanced
FT                   viral DNA synthesis."
FT                   /evidence="ECO:0000269|PubMed:33967989"
FT   STRAND          12..15
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   HELIX           17..26
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   HELIX           28..32
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          39..43
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   TURN            44..46
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          47..54
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          57..63
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   HELIX           65..67
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          68..71
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          78..84
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   HELIX           90..93
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          109..118
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          121..129
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          134..136
FT                   /evidence="ECO:0007829|PDB:1YYP"
FT   STRAND          144..148
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   HELIX           150..160
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          178..185
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   TURN            186..189
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          190..195
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          200..203
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   TURN            206..208
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          209..213
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          216..222
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   HELIX           223..233
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   HELIX           234..236
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          240..257
FT                   /evidence="ECO:0007829|PDB:1T6L"
FT   STRAND          259..268
FT                   /evidence="ECO:0007829|PDB:1T6L"
SQ   SEQUENCE   433 AA;  46233 MW;  E3BDF4C05E4C040A CRC64;
     MDRKTRLSEP PTLALRLKPY KTAIQQLRSV IRALKENTTV TFLPTPSLIL QTVRSHCVSK
     ITFNSSCLYI TDKSFQPKTI NNSTPLLGNF MYLTSSKDLT KFYVQDISDL SAKISMCAPD
     FNMEFSSACV HGQDIVRESE NSAVHVDLDF GVVADLLKWI GPHTRVKRNV KKAPCPTGTV
     QILVHAGPPA IKFILTNGSE LEFTANNRVS FHGVKNMRIN VQLKNFYQTL LNCAVTKLPC
     TLRIVTEHDT LLYVASRNGL FAVENFLTEE PFQRGDPFDK NYVGNSGKSR GGGGGGGSLS
     SLANAGGLHD DGPGLDNDLM NEPMGLGGLG GGGGGGGKKH DRGGGGGSGT RKMSSGGGGG
     DHDHGLSSKE KYEQHKITSY LTSKGGSGGG GGGGGGGLDR NSGNYFNDAK EESDSEDSVT
     FEFVPNTKKQ KCG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025